9342-8530 Quebec Inc DGCRF

Healthcare Biotechnology

Diagnocure Inc is a Canada based biotechnology company. It is primarily engaged in the business activity of development and commercialization of products relating to the diagnosis of cancer. The group generates its revenue from research and license agreement. The head office of the company is located in Quebec, Canada.

GREY:DGCRF - Post by User

9342-8530 Quebec Inc > Options @ $0.11

<< Previous

Bullboard Posts

Next >>

Post by Dibah42on Feb 06, 2015 7:51am

185 Views

Post# 23402883

Options @ $0.11

Latest 10 SEDI filings (by transaction date) for CUR within the last 6 months	[?]
Amended Filing

					As of 11:59pm ET February 5th, 2015
Filing Date	Transaction Date	Insider Name	Ownership Type	Securities	Nature of transaction	# or value acquired or disposed of	Price
Feb 5/15	Feb 4/15	Simoneau, Jacques	Direct Ownership	Options	50 - Grant of options	23,723	$0.110
Feb 5/15	Feb 4/15	Zurawski, Vincent R.	Direct Ownership	Options	50 - Grant of options	18,978	$0.110
Feb 5/15	Feb 4/15	Sheldon, Andrew J.	Direct Ownership	Options	50 - Grant of options	18,978	$0.110
Feb 5/15	Feb 4/15	Proulx, Louise	Direct Ownership	Options	50 - Grant of options	23,723	$0.110
Feb 5/15	Feb 4/15	Fradet, Yves	Direct Ownership	Options	50 - Grant of options	50,000	$0.110
Feb 5/15	Feb 4/15	Boivin, Frederic	Direct Ownership	Options	50 - Grant of options	5,000	$0.110
Feb 5/15	Feb 4/15	Allard, Danielle	Direct Ownership	Options	50 - Grant of options	5,000	$0.110
Dec 16/14	Dec 16/14	Axelrod, Todd M.	Indirect Ownership	Common Shares	00 - Opening Balance-Initial SEDI Report	1,156,500
Dec 16/14	Dec 16/14	Axelrod, Todd M.	Direct Ownership	Common Shares	00 - Opening Balance-Initial SEDI Report	7,402,500
Nov 3/14	Nov 1/14	Zurawski, Vincent R.	Direct Ownership	Options	52 - Expiration of options	-20,000	$4.23